Literature DB >> 19651628

Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer.

Y Shi1, X Ding, Z-H He, K-C Zhou, Q Wang, Y-Z Wang.   

Abstract

BACKGROUND: Oesophageal squamous cell carcinoma (OSCC) is one of the leading causes of cancer-related death worldwide. However, the mechanism by which the OSCC develops remains largely unknown. Ion channels are important for cancer development. Whether the transient receptor potential canonical (TRPC), known as the non-selective cation channels, plays a role in OSCC development is unknown.
METHODS: The expression of TRPC6, a member of TRPC subfamily, was examined in samples from patients with OSCC by immunostaining and in situ hybridisation. The effects of TRPC6 channels on OSCC cell cycle progression, cell growth and in vivo tumour formation were investigated. The functional TRPC6 channels were found in OSCC cells by electrophysiology and Ca(2+) imaging analysis.
RESULTS: The expression of TRPC6 at protein and mRNA levels was markedly increased in human OSCC specimens than that in normal human oesophageal tissues. Blockade of TRPC6 channels in human OSCC cells inhibited elevation of intracellular Ca(2+) concentration ([Ca(2+)](i)) and activation of Cdc2 kinase. Meanwhile, the OSCC cell cycle was arrested at G2 phase and the cell growth was suppressed. Furthermore, inhibition of TRPC6 channels suppressed in nude mice the tumour formation generated by injection of the OSCC cells.
CONCLUSION: TRPC6 channels play a critical role in the development of OSCC. The [Ca(2+)](i) elevation regulated by TRPC6 channels is essential for G2 phase progression and OSCC development. These channels might be a novel target for therapeutic intervention of OSCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651628     DOI: 10.1136/gut.2009.181735

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

Review 2.  Calcium channels and pumps in cancer: changes and consequences.

Authors:  Gregory R Monteith; Felicity M Davis; Sarah J Roberts-Thomson
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

3.  Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells.

Authors:  A A Peters; S Y N Jamaludin; K T D S Yapa; S Chalmers; A P Wiegmans; H F Lim; M J G Milevskiy; I Azimi; F M Davis; K S Northwood; E Pera; D L Marcial; E Dray; N J Waterhouse; P J Cabot; T J Gonda; P A Kenny; M A Brown; K K Khanna; S J Roberts-Thomson; G R Monteith
Journal:  Oncogene       Date:  2017-07-31       Impact factor: 9.867

4.  The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers.

Authors:  Ying Hou; Qifei Zou; Ruiliang Ge; Feng Shen; Yizheng Wang
Journal:  Cell Res       Date:  2011-08-23       Impact factor: 25.617

5.  The role of TRPC6 in HGF-induced cell proliferation of human prostate cancer DU145 and PC3 cells.

Authors:  Yong Wang; Dan Yue; Kai Li; Yi-Li Liu; Chang-Shan Ren; Ping Wang
Journal:  Asian J Androl       Date:  2010-09-13       Impact factor: 3.285

6.  Critical role of TRPC6 channels in the development of human renal cell carcinoma.

Authors:  Jiayin Song; Yong Wang; Xue Li; Yanna Shen; Meilin Yin; Yuhong Guo; Lei Diao; Yunde Liu; Dan Yue
Journal:  Mol Biol Rep       Date:  2013-05-23       Impact factor: 2.316

7.  High expression of transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Shui-Shen Zhang; Jing Wen; Fu Yang; Xiao-Li Cai; Hong Yang; Kong-Jia Luo; Qian Wen Liu; Rong-Gui Hu; Xuan Xie; Qing-Yuan Huang; Jun Ying Chen; Jian Hua Fu; Yi Hu
Journal:  Med Oncol       Date:  2013-05-18       Impact factor: 3.064

8.  Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.

Authors:  Xiang Song; Bing-Chen Liu; Xiao-Yu Lu; Li-Li Yang; Yu-Jia Zhai; Amity F Eaton; Tiffany L Thai; Douglas C Eaton; He-Ping Ma; Bao-Zhong Shen
Journal:  Biochim Biophys Acta       Date:  2014-02-08

9.  Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Kun Zhou; Shui-Shen Zhang; Yan Yan; Song Zhao
Journal:  Med Oncol       Date:  2014-05-31       Impact factor: 3.064

Review 10.  New insights into pharmacological tools to TR(i)P cancer up.

Authors:  M Gautier; I Dhennin-Duthille; A S Ay; P Rybarczyk; I Korichneva; H Ouadid-Ahidouch
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.